fexofenadine has been researched along with Inflammatory Bowel Diseases in 1 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, X | 1 |
| Liu, R | 1 |
| Chen, Y | 1 |
| Hettinghouse, A | 1 |
| Liu, C | 1 |
1 other study available for fexofenadine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Cytosolic Phospholipase A2 Is Required for Fexofenadine's Therapeutic Effects against Inflammatory Bowel Disease in Mice.
Topics: Animals; Biomarkers, Pharmacological; Disease Models, Animal; Inflammatory Bowel Diseases; Mice; Mic | 2021 |